- Trials with a EudraCT protocol (289)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (11)
289 result(s) found for: Pulmonary Artery.
Displaying page 1 of 15.
EudraCT Number: 2010-019352-42 | Sponsor Protocol Number: R09246M | Start Date*: 2010-08-19 | |||||||||||
Sponsor Name:Heart Center Co. Tampere University Hospital | |||||||||||||
Full Title: Effects of hypertonic saline-hydroxyethylstarch solution on extracellular water in cardiac surgery patients | |||||||||||||
Medical condition: Fifty adult male patients undergoing coronary bypass surgery will be enrolled in this study. Inclusion criteria are male gender and no need for pulmonary artery catheter (pulmonary hypertension or... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003843-28 | Sponsor Protocol Number: STH13565 | Start Date*: 2005-03-18 |
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | ||
Full Title: The acute effects of testosterone administration in patients with pulmonary hypertension | ||
Medical condition: Pulmonary Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001090-14 | Sponsor Protocol Number: P130925 | Start Date*: 2014-09-25 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001529-15 | Sponsor Protocol Number: RATIOSTUDY | Start Date*: 2016-10-26 | |||||||||||
Sponsor Name:AZIENDA SOCIO-SANITARIA TERRITORIALE DI LECCO (ASST LECCO) | |||||||||||||
Full Title: Randomized Anticoagulation Trial In Opcab HIGH DOSE VERSUS LOW DOSE HEPARINIZATION IN PATIENTS | |||||||||||||
Medical condition: Off-pump coronary artery bypass grafting (OPCAB) is an established alternative to on-pump coronary artery bypass grafting (CABG), OPCAB, like any other surgical procedure, determines a pro-coagulan... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023839-42 | Sponsor Protocol Number: H8O-CY-O027 | Start Date*: 2011-04-29 | ||||||||||||||||
Sponsor Name:General University Hospital in Prague | ||||||||||||||||||
Full Title: EXEnatide in patients undergoing Coronary artery bypass grafting for improved glUcose conTrol and hemodynamIc ValuEs | ||||||||||||||||||
Medical condition: Patients with elective coronary artery bypass grafting with LV systolic dysfunction (EF LV ≤ 50%) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000347-14 | Sponsor Protocol Number: PROCLAIM | Start Date*: 2016-06-16 | ||||||||||||||||
Sponsor Name:IDIBAPS | ||||||||||||||||||
Full Title: Cell proliferation in pulmonary hypertension: mollecular imaging detection by FDG PET. Comparative study between patients and healthy subjects | ||||||||||||||||||
Medical condition: Pulmonary artery hypertension and thromboembolic chronic pulmonary hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005361-19 | Sponsor Protocol Number: 123-2006 | Start Date*: 2007-03-09 | |||||||||||
Sponsor Name:St Georges Hospital | |||||||||||||
Full Title: Evaluation of the efficacy of the dual endothelin 1 receptor antagonist Bosentan in the treatment of Pulmonary Hypertension secondary to Chronic Obstructive Pulmonary Disease and in the treatment o... | |||||||||||||
Medical condition: Pulmonary Hypertension secondary to Chronic Obstructive Pulmonary Disease and secondary to Sarcoid Patients devolop pulmonary hypertension for various reasons, two common causes are Chronic Obstru... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002036-28 | Sponsor Protocol Number: VTETumor02 | Start Date*: 2007-09-05 | ||||||||||||||||
Sponsor Name:Universitätsklinikum Essen | ||||||||||||||||||
Full Title: Prospektive, randomisierte, kontrollierte, unizentrische, offene, Studie zur Thromboembolieprophylaxe mit Enoxaparin bei nicht-chirurgischen onkologischen Patienten unter systemischer antineopla... | ||||||||||||||||||
Medical condition: to be used as prophylactic agent for thrombosis and pulmonary embolism in cancer patients | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020153-14 | Sponsor Protocol Number: HFpEF | Start Date*: 2011-01-12 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Effects of Sildenafil on pulmonary artery pressure in patients with heart failure with preserved ejection fraction and pulmonary hypertension | ||
Medical condition: The condition to be investigated is isolated left heart failure , also called heart failure with preserved ejection fraction ( HFpEF) with pulmonary hypertension. HFpEF is a clinical syndrome wit... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002019-97 | Sponsor Protocol Number: EX0401ES | Start Date*: 2005-01-25 | |||||||||||
Sponsor Name:FARMACUSI, S.A. | |||||||||||||
Full Title: Long term subcutaneous tinzaparin compared with tinzaparin and oral anticoagulants in the treatment of acute pulmonary embolism. A multicentre, prospective, randomised, open, parallel group clinica... | |||||||||||||
Medical condition: Patients with clinical suspicion of Pulmonar Thromboembolism confirmed according to the PIOPED criteria. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003181-12 | Sponsor Protocol Number: HOTPOT1 | Start Date*: 2016-10-07 |
Sponsor Name:Royal College of Surgeons in Ireland | ||
Full Title: Can sonographic assessment of pulmonary vascular reactivity following maternal hyperoxygenation therapy predict neonatal outcome in fetuses at risk of pulmonary hypertension? | ||
Medical condition: Persistent pulmonary hypertension of the newborn (PPHN) is a relatively common condition occurring in 7/1000 births and can result in significant cardiovascular instability in the newborn. It occur... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-018763-42 | Sponsor Protocol Number: 2008CV17 | Start Date*: 2010-07-14 | ||||||||||||||||
Sponsor Name:University of Dundee | ||||||||||||||||||
Full Title: Do Phosphodiesterase 5 Inhibitors Improve Exercise Capacity in COPD Patients with Pulmonary Hypertension? | ||||||||||||||||||
Medical condition: Chronic obstructive pulmonary disease Pulmonary hypertension (secondary to chronic obstructive pulmonary disease) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-022468-11 | Sponsor Protocol Number: ULTIMA08 | Start Date*: 2010-11-10 | |||||||||||
Sponsor Name:EKOS Corporation | |||||||||||||
Full Title: Ultrasound Accelerated Thombolysis of Pulmonary Embolism | |||||||||||||
Medical condition: Patients with acute symptomatic PE confirmed by contrast-enhanced chest CT with embolus located in at least one main or proximal lower lobe pulmonary artery and an end-diastolic diameter RV/LV rati... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002835-17 | Sponsor Protocol Number: 250774 | Start Date*: 2016-01-18 | ||||||||||||||||||||||||||
Sponsor Name:Justus Liebig Universität Gießen | ||||||||||||||||||||||||||||
Full Title: Investigation of the influence of PAH-specific medication on right ventricular function in patients with pulmonary arterial hypertension (PAH) under basal conditions | ||||||||||||||||||||||||||||
Medical condition: Pulmonary arterial Hypertension (PAH) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Restarted) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003921-13 | Sponsor Protocol Number: 12/0368 | Start Date*: 2013-06-07 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: COMbination therapy for PulmonAry hypertension using RacEcadotril (COMPARE). | |||||||||||||
Medical condition: Pulmonary hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003975-38 | Sponsor Protocol Number: TERPAH-001 | Start Date*: 2007-11-22 | |||||||||||
Sponsor Name:Ergonex Pharma GmbH | |||||||||||||
Full Title: Proof of Concept Study to Investigate the Efficacy, Haemodynamics and Tolerability of Terguride vs. Placebo in Patients with Pulmonary Arterial Hypertension. Double-blind, randomized, prospective P... | |||||||||||||
Medical condition: Pulmonary arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) NL (Completed) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005032-30 | Sponsor Protocol Number: 2021-PDNO-003 | Start Date*: 2022-05-16 | |||||||||||
Sponsor Name:Attgeno AB | |||||||||||||
Full Title: An open-label, multicenter study to evaluate the DOSE, efficacy, safety and tolerability of PDNO (Nitrosooxypropanol) infusion in patients with pulmonary hypertension after cardiopulmonary bypass (... | |||||||||||||
Medical condition: Acute Pulmonary Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003273-42 | Sponsor Protocol Number: 14AOI11 | Start Date*: 2014-12-23 | |||||||||||
Sponsor Name:CHU de Nice | |||||||||||||
Full Title: Comparing a diuretic vascular filling in the initial management of acute pulmonary embolism with right ventricular dysfunction normotensive | |||||||||||||
Medical condition: acute pulmonary embolism with right ventricular dysfunction normotensive | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001643-21 | Sponsor Protocol Number: 2007OE002B | Start Date*: 2008-06-26 | |||||||||||
Sponsor Name:Royal Brompton and Harefield NHS Trust | |||||||||||||
Full Title: Use of endothelin-1 antagonists in patients with Established Pulmonary Hypertension and Fibrotic Lung Disease. – A randomised, placebo-controlled, double-blinded study. | |||||||||||||
Medical condition: Pulmonary hypertension in patients with interstitial lung disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001525-28 | Sponsor Protocol Number: ICL-INONAC1 | Start Date*: 2006-03-24 |
Sponsor Name:Imperial College London | ||
Full Title: INFLUENCE OF THE ANTIOXIDANT N-ACETYLCYSTEINE ON INHALED NITRIC OXIDE INDUCED PULMONARY RESPONSES FOLLOWING HUMAN LUNG ISCHAEMIA-REPERFUSION INJURY | ||
Medical condition: heart-lung transplantation | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.